Phase 2, Open-label, Study of KD025 in Subjects With Psoriasis Vulgaris Who Failed First-line Therapy
Clinical trial NCT02317627 · COMPLETED
Trial details
- NCT number
- NCT02317627
- Sponsor
- Kadmon Corporation, LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-12-01
- Primary completion
- 2016-03-01
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.